SKI Market

A+| A| A-|

Indian Indices

Sensex

75,415.35 0.00
( 0.00%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

63,328.42 1,644.28
(2.67%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

87.27

9644.14

EPS(TTM)

Face Value()

Div & Yield %

5.65

0.1

Back

iifl capital services ltd

Cholamandalam Investment & Finance Company consolidated net profit rises 18.54% in the December 2025 quarter

Jan 31,2026

Net profit of Cholamandalam Investment & Finance Company rose 18.54% to Rs 1289.97 crore in the quarter ended December 2025 as against Rs 1088.21 crore during the previous quarter ended December 2024. Sales rose 17.31% to Rs 7898.21 crore in the quarter ended December 2025 as against Rs 6732.98 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	7898.21	6732.98	17
OPM %	67.66	69.73	-
PBDT	1809.52	1524.80	19
PBT	1735.74	1465.65	18
NP	1289.97	1088.21	19

75,415.35 0.00 ( 0.00%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

63,328.42 1,644.28 (2.67%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)